Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOLT: Sonidegib in advanced basal cell carcinoma
NCT01327053Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2011
- Primary completion
- Jun 2013
- Modality
- Allosteric Modulators
- Countries
- 12
01
Overview
A Phase 2 trial of sonidegib in basal cell carcinoma (BCC), sponsored by Novartis. Started Jun 2011; status: completed.
02
Drugs
sonidegib
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT01327053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327053.